Skip to main content
Caplight Logo









Zehui Biotechnology

Zehui Biotechnology

Private
BeijingHealthcare & Life Scienceshttps://zephyrm.com/

Last Round

Series B

Mar 1, 2023

Est. Valuation

$327.56M

Total Funding Raised

$83.14M

Company Overview

Zehui Biotechnology is a biopharmaceutical company that develops innovative cell therapy products derived from pluripotent stem cells to treat various diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

pluripotent stem cellsPSCcell therapyregenerative medicinebiopharmaceuticalgraft-versus-host diseaseaGVHDclinical researchdrug developmentimmune regulationtissue regenerationbiotech startupclinical trialsstem cell researchcell therapy pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zehui Biotechnology Comparables

Compare Zehui Biotechnology with similar companies based on industry and business-model similarity.

Zehui Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Guangzhou Saijun Biotechnology Co., Ltd.
84%
Help Therapeutics
80%
iRegene Therapeutics
79%

Zehui Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 1, 2023
VC RoundApr 1, 2021
Series ADec 1, 2020
AngelSep 1, 2019

Zehui Biotechnology Investors

Notable investors and investment history

Zehui Biotechnology investors
InvestorRounds
Bencao CapitalVC Round
Guokejiahe FundVC Round
CAS StarAngel
CCB Trust Co., Ltd.Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2020

    $24M round led by Beijing Guoke Dingzhi Equity Investment Center.

  • Sep 1, 2019

    $14M raised from CAS Star.

Zehui Biotechnology Filings

Explore SEC and related filing metadata, where available.

Zehui Biotechnology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Zehui Biotechnology's valuation, stock price, and market status.

Is Zehui Biotechnology a public or private company?

Zehui Biotechnology is a private company.

What is the current stock price of Zehui Biotechnology?

Zehui Biotechnology is a private company with no public stock price. No recent secondary market data is available.

How much is Zehui Biotechnology worth (valuation)?

Zehui Biotechnology's valuation is estimated at $327.6M based on funding round data.

Can I buy Zehui Biotechnology stock?

Zehui Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Zehui Biotechnology's last funding round?

Zehui Biotechnology's most recent funding round was Series B on March 1, 2023.

Who are the main investors in Zehui Biotechnology?

Key investors in Zehui Biotechnology include CCB Trust Co., Ltd..

Will Zehui Biotechnology IPO soon?

No public IPO plans have been announced for Zehui Biotechnology.

How can I track Zehui Biotechnology secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Zehui Biotechnology's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeijing
Year Founded2017
Last FundingMar 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?